PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1909402
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1909402
The EU point-of-care ultrasound (POCUS) device market is witnessing steady growth as healthcare providers increasingly adopt portable and real-time imaging solutions to enhance clinical decision-making and patient outcomes. The market is valued at USD 245.0 million in 2025 and is projected to reach USD 392.7 million by 2032, growing at a CAGR of 7% during the study period from 2021 to 2032. Rising demand for rapid diagnostics, bedside imaging, and workflow efficiency across hospitals and outpatient settings is driving sustained market expansion.
POCUS devices are becoming integral to emergency care, critical care, anesthesia, cardiology, and primary care by enabling immediate visualization and faster diagnosis. Advancements in device portability, image quality, and integration with digital health platforms are improving usability and expanding clinical applications. Increasing emphasis on early diagnosis, cost-effective care delivery, and reduction of diagnostic delays is further reinforcing market momentum across the EU.
Germany represents the largest country-level market, supported by advanced healthcare infrastructure, high adoption of diagnostic imaging technologies, and strong clinical demand, while the U.K. is emerging as the fastest-growing country due to expanding use of point-of-care diagnostics, rising adoption in emergency and primary care settings, and growing investment in healthcare technology modernization. As healthcare systems across the EU continue to prioritize efficiency and rapid diagnostics, the POCUS device market is expected to maintain steady growth throughout the forecast period.
Key Insights
The EU POCUS device market is valued at USD 245.0 million in 2025 and is expected to reach USD 392.7 million by 2032, reflecting steady long-term growth driven by rapid diagnostic needs.
The market is projected to grow at a CAGR of 7% during 2021-2032, supported by increasing adoption of portable and real-time imaging solutions.
Growing demand for bedside diagnostics and faster clinical decision-making is strengthening POCUS device adoption.
Germany accounts for the largest share of the market, driven by advanced healthcare infrastructure and strong diagnostic imaging utilization.
The U.K. is the fastest-growing country, supported by expanding use of point-of-care diagnostics across emergency and primary care settings.
Advancements in device portability and imaging quality are expanding clinical applications of POCUS devices.
Increasing integration of ultrasound devices with digital health systems is improving workflow efficiency and data accessibility.
Rising focus on cost-effective and time-efficient diagnostic solutions is influencing healthcare technology investments.
Expansion of outpatient and ambulatory care services is increasing demand for portable imaging devices.
Continued investment in healthcare modernization, diagnostic technology, and clinical training is expected to sustain long-term growth in the EU POCUS device market.